Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial (Q80693786)
Jump to navigation
Jump to search
scientific article published on 28 July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial |
scientific article published on 28 July 2007 |
Statements
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial (English)
S Lorenzen
M Hentrich
C Haberl
V Heinemann
T Schuster
T Seroneit
N Roethling
C Peschel